These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23483221)

  • 21. N-terminal proB-type natriuretic peptide levels aid the diagnosis of left ventricular dysfunction in patients with severe acute exacerbations of chronic obstructive pulmonary disease and renal dysfunction.
    Ouanes I; Jalloul F; Ayed S; Dachraoui F; Ouanes-Besbes L; Fekih Hassen M; Elatrous S; Abroug F
    Respirology; 2012 May; 17(4):660-6. PubMed ID: 22348741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Association of Five-Year Changes in the Levels of N-Terminal Fragment of the Prohormone Brain-Type Natriuretic Peptide (NT-proBNP) with Subsequent Heart Failure and Death in Patients with Stable Coronary Artery Disease: The Heart and Soul Study.
    Mishra RK; Judson G; Christenson RH; DeFilippi C; Wu AHB; Whooley MA
    Cardiology; 2017; 137(4):201-206. PubMed ID: 28445886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction.
    Costello-Boerrigter LC; Boerrigter G; Redfield MM; Rodeheffer RJ; Urban LH; Mahoney DW; Jacobsen SJ; Heublein DM; Burnett JC
    J Am Coll Cardiol; 2006 Jan; 47(2):345-53. PubMed ID: 16412859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NT-probrain natriuretic peptide predicts complexity and severity of the coronary lesions in patients with non-ST-elevation acute coronary syndromes.
    Navarro Estrada JL; Rubinstein F; Bahit MC; Rolandi F; Perez de Arenaza D; Gabay JM; Alvarez J; Sarmiento R; Rojas Matas C; Sztejfman C; Tettamanzi A; de Miguel R; Guzman L;
    Am Heart J; 2006 May; 151(5):1093.e1-7. PubMed ID: 16644341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relation between NT-proBNP levels, iron overload, and early stage of myocardial dysfunction in β-thalassemia major patients.
    Balkan C; Tuluce SY; Basol G; Tuluce K; Ay Y; Karapinar DY; Gurgun C; Bayindir O; Kavakli K
    Echocardiography; 2012 Mar; 29(3):318-25. PubMed ID: 22066516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N-terminal pro-B-type natriuretic peptide as a diagnostic test for ventricular dysfunction in patients with coronary disease: data from the heart and soul study.
    Corteville DC; Bibbins-Domingo K; Wu AH; Ali S; Schiller NB; Whooley MA
    Arch Intern Med; 2007 Mar; 167(5):483-9. PubMed ID: 17353496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relationship between serum NT-proBNP levels and severity of coronary artery disease assessed by SYNTAX score in patients with acute myocardial infarction.
    Sarak T; Karadeniz M
    Turk J Med Sci; 2019 Oct; 49(5):1366-1373. PubMed ID: 31648513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of metabolic syndrome and diabetes mellitus on the N-terminal pro-B-type natriuretic peptide level and its prognostic performance in patients with coronary artery disease.
    Huang FY; Peng Y; Deng XX; Huang BT; Xia TL; Gui YY; Liu RS; Yang Y; Pu XB; Chen SJ; Chen F; Zhu Y; Chen M
    Coron Artery Dis; 2017 Mar; 28(2):159-165. PubMed ID: 28045698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NT-proBNP and BNP values in cardiac patients with different degree of left ventricular systolic dysfunction.
    Kotaska K; Popelova J; Tiserova M; Telekes P; Vrzanova M; Bronsky J; Halacova M; Kukacka J; Prusa R
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2006 Jul; 150(1):125-30. PubMed ID: 16936915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pro-brain natriuretic peptide plasma levels, left ventricular dimensions and ejection fraction in acute dyspnoea.
    Shaikh K; Hanif B; Siddique AA; Shaikh MY; Khan MN
    J Coll Physicians Surg Pak; 2012 Dec; 22(12):751-5. PubMed ID: 23217478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-terminal-proB natriuretic peptide in patients with stable coronary artery disease evaluated for ischemia with myocardial perfusion imaging.
    Majstorov V; Pop GD; Vavlukis M; Peovska I; Maksimovik J; Vaskova O; Kuzmanovska S; Zdraveska-Kochovska M
    Bratisl Lek Listy; 2008; 109(7):293-7. PubMed ID: 18792482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is N-terminal pro B-type natriuretic peptide (NT-proBNP) a useful screening test for angiographic findings in patients with stable coronary disease?
    Kragelund C; Grønning B; Omland T; Køber L; Strande S; Steffensen R; Hildebrandt P
    Am Heart J; 2006 Mar; 151(3):712.e1-712.e7. PubMed ID: 16504637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N-terminal pro-brain natriuretic peptide predicts myocardial ischemia and is related to postischemic left-ventricular dysfunction in patients with stable coronary artery disease.
    Vanzetto G; Jacon P; Calizzano A; Neuder Y; Faure P; Fagret D; Machecourt J
    J Nucl Cardiol; 2007; 14(6):835-42. PubMed ID: 18022110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [N-terminal pro-brain natriuretic peptide levels and diastolic dysfunction in patients with early rheumatoid arthritis before the administration of disease-modifying antirheumatic drugs].
    Kirillova IG; Novikova DS; Popkova TV; Aleksandrova EN; Novikov AA; Gorbunova YN; Markelova EI; Korsakova YO; Glukhova SI; Volkov AV; Luchikhina EL; Demidova NV; Kasumova KA; Vladimirov SA; Kanonirova MA; Lukina GL; Karateev DE; Nasonov EL
    Ter Arkh; 2016; 88(5):19-26. PubMed ID: 27239922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation Between NT-pro BNP levels and left ventricular wall stress, sphericity index and extent of myocardial damage: a magnetic resonance imaging study.
    Krittayaphong R; Boonyasirinant T; Saiviroonporn P; Thanapiboonpol P; Nakyen S; Udompunturak S
    J Card Fail; 2008 Oct; 14(8):687-94. PubMed ID: 18926441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-terminal B-type natriuretic peptide concentrations are similarly increased by 30 minutes of moderate and brisk walking in patients with coronary artery disease.
    Scharhag J; Herrmann M; Weissinger M; Herrmann W; Kindermann W
    Clin Res Cardiol; 2007 Apr; 96(4):218-26. PubMed ID: 17323015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Clinical Value of N-Terminal Pro B-Type Natriuretic Peptide in Evaluating Obstructive Sleep Apnea in Patients With Coronary Artery Disease.
    Liu Y; Huang Z; Huang K; Li G; Luo J; Xu Y; Chen P; Chen J; Wang L
    J Clin Sleep Med; 2019 Oct; 15(10):1403-1409. PubMed ID: 31596204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct comparison of transcardiac increase in brain natriuretic peptide (BNP) and N-terminal proBNP and prognosis in patients with chronic heart failure.
    Tsutamoto T; Sakai H; Nishiyama K; Tanaka T; Fujii M; Yamamoto T; Horie M
    Circ J; 2007 Dec; 71(12):1873-8. PubMed ID: 18037739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-terminal pro B-type natriuretic peptide levels: correlation with echocardiographically determined left ventricular diastolic function in an ambulatory cohort.
    Dong SJ; de las Fuentes L; Brown AL; Waggoner AD; Ewald GA; Dávila-Román VG
    J Am Soc Echocardiogr; 2006 Aug; 19(8):1017-25. PubMed ID: 16880097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of clinical outcome in patients with non-ST-elevation acute coronary syndrome (NSTE-ACS) using the TIMI risk score extended by N-terminal pro-brain natriuretic peptide levels.
    Jarai R; Iordanova N; Jarai R; Jarai F; Raffetseder A; Woloszczuk W; Gyöngyösi M; Geyer G; Wojta J; Huber K
    Wien Klin Wochenschr; 2007; 119(21-22):626-32. PubMed ID: 18043882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.